These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 33878399)
61. Colistin resistance emerges in pandrug-resistant Klebsiella pneumoniae epidemic clones in Rio de Janeiro, Brazil. Longo LGA; de Sousa VS; Kraychete GB; Justo-da-Silva LH; Rocha JA; Superti SV; Bonelli RR; Martins IS; Moreira BM Int J Antimicrob Agents; 2019 Nov; 54(5):579-586. PubMed ID: 31479740 [TBL] [Abstract][Full Text] [Related]
62. Bacteriophage in the treatment of experimental septicemic mice from a clinical isolate of multidrug resistant Klebsiella pneumoniae. Vinodkumar CS; Neelagund YF; Kalsurmath S J Commun Dis; 2005 Mar; 37(1):18-29. PubMed ID: 16637396 [TBL] [Abstract][Full Text] [Related]
63. More than Rotating Flagella: Lipopolysaccharide as a Secondary Receptor for Flagellotropic Phage 7-7-1. Gonzalez F; Helm RF; Broadway KM; Scharf BE J Bacteriol; 2018 Oct; 200(19):. PubMed ID: 30012730 [TBL] [Abstract][Full Text] [Related]
64. Isolation and Characterization of a Novel Lytic Bacteriophage against the K2 Capsule-Expressing Hypervirulent Pertics BZ; Cox A; Nyúl A; Szamek N; Kovács T; Schneider G Microorganisms; 2021 Mar; 9(3):. PubMed ID: 33801047 [No Abstract] [Full Text] [Related]
65. New Bacteriophages against Emerging Lineages ST23 and ST258 of Thiry D; Passet V; Danis-Wlodarczyk K; Lood C; Wagemans J; De Sordi L; van Noort V; Dufour N; Debarbieux L; Mainil JG; Brisse S; Lavigne R Viruses; 2019 May; 11(5):. PubMed ID: 31058805 [No Abstract] [Full Text] [Related]
66. Emergence and dissemination of colistin-resistant Klebsiella pneumoniae isolates expressing OXA-48 plus CTX-M-15 in patients not previously treated with colistin in a Spanish university hospital. Barragán-Prada H; Ruiz-Hueso P; Tedim AP; González-Candelas F; Galán JC; Cantón R; Morosini MI Diagn Microbiol Infect Dis; 2019 Feb; 93(2):147-153. PubMed ID: 30266401 [TBL] [Abstract][Full Text] [Related]
67. Characterization and genome analysis of Klebsiella phage P509, with lytic activity against clinical carbapenem-resistant Klebsiella pneumoniae of the KL64 capsular type. Li M; Xiao Y; Li P; Wang Z; Qi W; Qi Z; Chen L; Du H; Zhang W Arch Virol; 2020 Dec; 165(12):2799-2806. PubMed ID: 32989574 [TBL] [Abstract][Full Text] [Related]
68. Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice. Chhibber S; Kaur S; Kumari S J Med Microbiol; 2008 Dec; 57(Pt 12):1508-1513. PubMed ID: 19018021 [TBL] [Abstract][Full Text] [Related]
69. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae. Poirel L; Jayol A; Bontron S; Villegas MV; Ozdamar M; Türkoglu S; Nordmann P J Antimicrob Chemother; 2015 Jan; 70(1):75-80. PubMed ID: 25190723 [TBL] [Abstract][Full Text] [Related]
70. Influence of environmental conditions on infection of Klebsiella pneumoniae by two different types of bacteriophages. Benedí VJ; Regué M; Albertí S; Camprubí S; Tomás JM Can J Microbiol; 1991 Apr; 37(4):270-5. PubMed ID: 1913339 [TBL] [Abstract][Full Text] [Related]
72. Structure of the core oligosaccharide in the serotype O8 lipopolysaccharide from Klebsiella pneumoniae. Severn WB; Kelly RF; Richards JC; Whitfield C J Bacteriol; 1996 Mar; 178(6):1731-41. PubMed ID: 8626303 [TBL] [Abstract][Full Text] [Related]
73. Emergence of colistin-resistant Klebsiella pneumoniae in Poland. Sękowska A; Chudy M; Gospodarek-Komkowska E Acta Microbiol Immunol Hung; 2019 Dec; 67(1):18-22. PubMed ID: 31813256 [TBL] [Abstract][Full Text] [Related]
74. Inactivation of mgrB gene regulator and resistance to colistin is becoming endemic in carbapenem-resistant Klebsiella pneumoniae in Greece: A nationwide study from 2014 to 2017. Hamel M; Chatzipanagiotou S; Hadjadj L; Petinaki E; Papagianni S; Charalampaki N; Tsiplakou S; Papaioannou V; Skarmoutsou N; Spiliopoulou I; Christofidou M; Papamichalopoulos N; Skalidis T; Legakis N; Fountoulis K; Perivolioti E; Kraniotaki H; Bournia M; Ioannidis A; Baron Sophie A; Rolain JM Int J Antimicrob Agents; 2020 Apr; 55(4):105930. PubMed ID: 32130981 [TBL] [Abstract][Full Text] [Related]
75. Role of capsule and O antigen in resistance of Klebsiella pneumoniae to serum bactericidal activity. Tomás JM; Benedí VJ; Ciurana B; Jofre J Infect Immun; 1986 Oct; 54(1):85-9. PubMed ID: 3531020 [TBL] [Abstract][Full Text] [Related]
76. Genetic determinants of host tropism in Klebsiella phages. Beamud B; García-González N; Gómez-Ortega M; González-Candelas F; Domingo-Calap P; Sanjuan R Cell Rep; 2023 Feb; 42(2):112048. PubMed ID: 36753420 [TBL] [Abstract][Full Text] [Related]
77. Global Trends in Proteome Remodeling of the Outer Membrane Modulate Antimicrobial Permeability in Klebsiella pneumoniae. Rocker A; Lacey JA; Belousoff MJ; Wilksch JJ; Strugnell RA; Davies MR; Lithgow T mBio; 2020 Apr; 11(2):. PubMed ID: 32291303 [TBL] [Abstract][Full Text] [Related]
78. Prevalence of the colistin resistance gene mcr-1 in colistin-resistant Escherichia coli and Klebsiella pneumoniae isolated from humans in Thailand. Eiamphungporn W; Yainoy S; Jumderm C; Tan-Arsuwongkul R; Tiengrim S; Thamlikitkul V J Glob Antimicrob Resist; 2018 Dec; 15():32-35. PubMed ID: 29935331 [TBL] [Abstract][Full Text] [Related]
79. Evidence to support the therapeutic potential of bacteriophage Kpn5 in burn wound infection caused by Klebsiella pneumoniae in BALB/c mice. Kumari S; Harjai K; Chhibber S J Microbiol Biotechnol; 2010 May; 20(5):935-41. PubMed ID: 20519918 [TBL] [Abstract][Full Text] [Related]
80. Physiochemical characterization of a potential Das S; Kaledhonkar S Front Microbiol; 2024; 15():1397447. PubMed ID: 39086652 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]